Best Agrolife, a leading agrochemical manufacturer in India, has announced its medium to long-term target to gain 15-20 per cent market share. The company is also enhancing its manufacturing capabilities through ‘brown field’ and ‘green field’ capex plans.
Besides, the company is also seeking 25-30 per cent growth in revenue by increasing the share of the Formulation Business and B2C segment. This will also ensure consistency in healthy EBITDA delivery, offering a better return on equity. Additionally, the company is spreading its footholds in the overseas markets in FY 2023-24 to replicate its domestic success story with selective offerings, ensuring sustainable and healthy profit margins.
“Best Agro is working proactively to maintain its leadership position. The investment plans aim to build the company’s manufacturing capabilities, create backward integration in its manufacturing process, and improvise gross margin and working capital management. Along with investments, we believe that schemes such as ‘Make in India’, and production-linked incentives (PLI) will boost domestic production, leading to the sector’s and the company’s growth. We are also expanding our footholds in the overseas markets,” said Vimal Alawadhi, MD, Best Agrolife.
You may also like to read: Astec LifeSciences launches R&D Center to develop new crop protection formulations
The company is also optimistic about the long-term benefits of simplifying the export registration process, reducing trade barriers, and improving focus on bilateral trade agreements to enhance revenue generation through exports.
Best Agrolife is listed among the top 15 agrochemical companies in India. It is a research-based company focused on bringing crop solutions in the form of agrochemical formulations to the agricultural industry to improve crop productivity. BAL currently has more than 5200 distributors in India. It retains an impressive portfolio of over 400 formulations and more than 100 technical manufacturing licences.
